Two-photon photodynamic therapy and its potential application to age related macular degeneration

Two-photon photodynamic therapy and its potential application to age related macular degeneration

Photodynamic therapy (PDT) using verteporfin is widely used for treatment of age related macular degeneration (AMD). Due to non-perfect selectivity of the drug accumulation in the neovasculature some collateral damage to healthy tissue arises during the treatment. Damage to healthy structures in the...

Полное описание

Библиографические подробности
Главные авторы:	Karotki, A, Khurana, M, Bisland, S, Moriyama, E, Simpson, E, Campbell, M, Collins, H, Anderson, H, Cramb, D, Wilson, B
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.
по: Khurana, M, и др.
Опубликовано: (2007)

In vitro studies of the efficiency of two-photon activation of photodynamic therapy agents
по: Khurana, M, и др.
Опубликовано: (2006)

MEDI 272-Two-photon excited photodynamic therapy using water-soluble porphyrin dimers
по: Balaz, M, и др.
Опубликовано: (2007)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
по: Alvaro Rodriguez, и др.
Опубликовано: (2014-09-01)

Multi-modality optical imaging of vascular responses to photodynamic therapy in mouse window chamber model
по: Khurana, M, и др.
Опубликовано: (2008)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
по: Jos&eacute; M&ordf; Ruiz-Moreno, и др.
Опубликовано: (2008-03-01)

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
по: BC Reeves, и др.
Опубликовано: (2012-02-01)

Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths.
по: Balaz, M, и др.
Опубликовано: (2009)

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration
по: Shuting Xu, и др.
Опубликовано: (2023-11-01)

Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
по: Kyoko Okada, и др.
Опубликовано: (2009-09-01)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
по: Mamdouh M Kabeel, и др.
Опубликовано: (2008-03-01)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
по: Tomoko Nakamura, и др.
Опубликовано: (2012-01-01)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
по: Azarmina Mohsen, и др.
Опубликовано: (2007-06-01)

Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
по: Tsuchihashi T, и др.
Опубликовано: (2014-12-01)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
по: Tsuchihashi T, и др.
Опубликовано: (2013-03-01)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
по: Jay Kumar Chhablani
Опубликовано: (2010-01-01)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
по: Min Ho Kim, и др.
Опубликовано: (2021-02-01)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
по: Pukhraj Rishi, и др.
Опубликовано: (2011-02-01)

Two-Photon Vision in Age-Related Macular Degeneration: A Translational Study
по: Grzegorz Łabuz, и др.
Опубликовано: (2022-03-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
по: Rosalia Giustolisi, и др.
Опубликовано: (2014-09-01)

On the efficiency of treatment of wet age-related macular degeneration with Lucentis
по: E. M. Kasimov, и др.
Опубликовано: (2018-10-01)

Age-related macular degeneration
по: Querques G, и др.
Опубликовано: (2011-05-01)

Age-related macular degeneration
по: Wanjiku Mathenge
Опубликовано: (2014-12-01)

MEDI 118-Conjugated porphyrin dimers with large two-photon absorption cross section for photodynamic therapy
по: Balaz, M, и др.
Опубликовано: (2007)

Photodynamic therapy and intravitreal bevacizumab with versus without triamcinolone for neovascular age-related macular degeneration; a randomized clinical trial
по: Niloofar Piri, и др.
Опубликовано: (2014-01-01)

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation
по: C. Meads, и др.
Опубликовано: (2003-01-01)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
по: Tvenning AO, и др.
Опубликовано: (2019-02-01)

Age-related macular degeneration and the aging eye
по: Rita Ehrlich, и др.
Опубликовано: (2008-09-01)

Photon energy upconversion in porphyrins: one-photon hot-band absorption versus two-photon absorption
по: Drobizhev, M, и др.
Опубликовано: (2003)

Gene therapy for age-related macular degeneration
по: MacLaren, RE
Опубликовано: (2015)

Targeted Therapy on Age-Related Macular Degeneration
по: Vankodoth Sireesha, и др.
Опубликовано: (2024-12-01)

Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration
по: A. E. Cheberda, и др.
Опубликовано: (2018-05-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
по: M. M. Bikbov, и др.
Опубликовано: (2019-08-01)

Age-Related Macular Degeneration and Circadian Preference
по: Garces E, и др.
Опубликовано: (2025-03-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
по: Sayah DN, и др.
Опубликовано: (2023-12-01)

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
по: Otsuji T, и др.
Опубликовано: (2016-03-01)

Pharmacogenetics and Age-Related Macular Degeneration
по: Stephen G. Schwartz, и др.
Опубликовано: (2011-01-01)

Choriocapillaris in Age-Related Macular Degeneration
по: Giovanni Neri, и др.
Опубликовано: (2024-08-01)

Nanotechnology for Age-Related Macular Degeneration
по: Bo Yang, и др.
Опубликовано: (2021-11-01)

Age-Related Macular or Retinal Degeneration?
по: Michalina Gałuszka, и др.
Опубликовано: (2023-05-01)